Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon) and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite. The company is headquartered in Natick, Massachusetts.

Allurion Technologies Inc.

Allurion was founded in 2009 with one mission: end obesity. The Allurion Program combines medical, digital, and nutritional approaches and engages an entire team to jumpstart weight loss and form lifelong healthy habits.

Allurion has already helped thousands of people around the world lose weight, develop lifelong healthy habits, and transform their lives, with over 100,000 balloons placed, and over 1,000,000kg lost worldwide.

10X Capital

Runway Growth Capital

Cogepa

The Family

IDO Investments

Romulus Capital

Novalis LifeSciences

Segulah Medical Acceleration

Jose Almeida

Allurion Technologies

Tune in to this episode of BBC 5 Live Breakfast in the UK, where Dr. Shantanu Gaur explains how the Allurion Balloon works, Prof. Richard Welbourn discusses the growing need for the Allurion Balloon within the UK’s National Health Service (NHS), and we meet Donna, the first ever NHS patient to receive the Allurion Balloon, which helped her lose an amazing 16kg.

Listen to the interview here [7mins 52s]: https://lnkd.in/es_M_FJe

#Allurion #AllurionProgram #Obesity #WeightLoss #Healthcare #GastricBalloon #AllurionVCS #VirtualCareSuite #BBC

With secure and enhanced communication between your clinic and your patients, the Allurion Virtual Care Suite is designed to make it easy to build trust, personalize care, and engage patients for longer in their program.

Explore our range of VCS plans here: https://lnkd.in/dyMH_H6k 

*Allurion online survey to VCS users - May 2023 - n=67 respondents. 

#Allurion #AllurionProgram #Obesity #WeightLoss #Healthcare #GastricBalloon #AllurionVCS #VirtualCareSuite

In case you missed it…

Allurion was recently featured in an array of UK publications as the Somerset NHS Foundation Trust became the first non-private sector organization in the world to introduce the Allurion Gastric Balloon to its patients.

Meet David Pulford from Somerset in the UK. He was one of the first patients to receive the Allurion Gastric Balloon through the NHS at Musgrove Park Hospital, where the BBC was in attendance to document and broadcast this milestone in healthcare.

To read the BBC article about David’s Allurion Balloon placement experience, click here: https://lnkd.in/eKWNuKQP

#Allurion #AllurionProgram #AllurionPartner #Obesity #WeightLoss #GastricBalloon #Healthcare #MedTech #MedicalDevice #NHS #PR #BBC

Made of durable yet flexible polyurethane and crafted to the shape of the stomach, the Allurion Balloon can help patients to lose 10-15% of their total body weight in approximately four months.*

Transform your offering by becoming an Allurion clinic partner today: https://lnkd.in/dtGSv5iq 

*Ienca et al. Obes Surg. 2020 2. Vantanasiri et al. Obes Surg 2020, 3. Ienca, Presented at TOS Obesity Week, 2020.

#Allurion #AllurionProgram #Obesity #WeightLoss #Healthcare #GastricBalloon

We’re excited to announce that we will be participating in the BTIG Snowbird MedTech, Digital Health, Life Science and Diagnostic Tools Conference taking place February 12 - 14, 2024.

Shantanu Gaur, Founder & CEO, and Christopher Geberth, Chief Financial Officer, will attend and be available for investor 1x1 meetings.

Click here to read the press release: https://lnkd.in/e9KW56uv 

#Allurion #AllurionProgram #Healthcare #GastricBalloon #BTIGSnowbirdConference

Our AI-powered weight-loss companion, Coach Iris, is designed to be there for your patients 24/7.

Built in close collaboration with leading global weight-management professionals and Allurion’s behavioral scientists, Coach Iris is available on our VCS+ and VCS Custom plans and can instantly expand the care team by providing always-on support, education, and motivation to patients.

Explore our VCS+ and VCS Custom plans to unlock access here: https://lnkd.in/dyMH_H6k  

#Allurion #AllurionProgram #Obesity #WeightLoss #Healthcare #GastricBalloon #AllurionVCS #AllurionVirtualCareSuite #AIinHealthcare

We are delighted to welcome Brendan Gibbons to Allurion as our new Chief Legal Officer and corporate secretary. 
 
Brendan joins Allurion with nearly 20 years’ experience as a chief legal and compliance officer at three separate public companies. In this new role, Brendan will lead Allurion's legal and compliance strategies, playing a pivotal part in guiding our global expansion and upholding our commitment to deliver safe and effective weight loss solutions.
 
Welcome, Brendan!
 
Click here to read the full press release: https://lnkd.in/eWGFp-yA 

#Allurion #AllurionProgram #Obesity #WeightLoss #GastricBalloon #Healthcare #MedTech #MedicalDevice #AllurionPR

The Allurion Program is a holistic weight-loss program centered around the world's first and only gastric balloon that does not require surgery, endoscopy or anesthesia**.

Combined with behavior change support to help your clinic team deliver more effective results for patients, the Allurion Program can result in an average total body weight loss of 10-15% for patients in just 16 weeks*.

Become an Allurion clinic partner today: https://lnkd.in/dtGSv5iq 

#Allurion #AllurionProgram #Obesity #WeightLoss #Healthcare #GastricBalloon

*Results at 16 weeks. Raftopoulos, I et al Holyoke Medical Center. Holyoke, MA An Intensive 52 Week Nutritional, Exercise and Behavior Modification Program: Comparing With or Without the Allurion IGB Presented at ASMBS 2018
**In rare cases, the Allurion Balloon may require endoscopic or surgical intervention for removal.

The Allurion Virtual Care Suite is a dynamic weight-loss management suite powered by artificial intelligence and designed to drive all your weight-loss programs to maximize your patient outcomes and satisfaction.

Remote patient monitoring, telehealth and improved care team collaboration – all under one digital umbrella.

Start with the Allurion VCS for free: https://lnkd.in/dyMH_H6k

#Allurion #AllurionProgram #Obesity #WeightLoss #Healthcare #GastricBalloon #AllurionVCS

	Dec '20	Dec '21	Dec '22	Dec '23
account payables		1.62M -	5.81M 259.02%	10.38M 78.67%
accumulated other comprehensive income loss				-700K -
cash and cash equivalents	47.09K -	25.84M 54,780.02%	7.68M 70.26%	38.04M 394.95%
cash and short term investments	47.09K -	25.84M 54,780.02%	7.68M 70.26%	38.04M 394.95%
common stock	2.16K -	51K 2,265.49%	51K 0%	5K 90.20%
deferred revenue		202K -
deferred revenue non current
deferrred tax liabilities non current
goodwill
goodwill and intangible assets
intangible assets
inventory		2.71M -	3.87M 42.36%	6.17M 59.66%
long term debt		2.00M -	5.27M 162.91%
long term investments
net debt	122.91K -	300K 144.08%	51.85M 17,182%	3.82M 92.63%
net receivables		6.83M -	29.35M 329.54%	18.19M 38.00%
other assets
other current assets		1.94M -	2.49M 28.46%	2.41M 2.94%
other current liabilities	140.13K -	11.30M 7,965.14%	15.79M 39.74%	15.49M 1.89%
other liabilities
other non current assets	282.88K -	311K 9.94%	2.71M 770.10%	505K 81.34%
other non current liabilities		40.02M -	41.67M 4.13%	76.77M 84.23%
othertotal stockholders equity	22.84K -	2.14M 9,263.51%	2.71M 26.51%	143.01M 5,184.81%
preferred stock		57.97M -	58.00M 0.04%
property plant equipment net		1.71M -	5.28M 208.11%	6.39M 21.02%
retained earnings	-5.17K -	-94.45M 1,827,100.62%	-132.19M 39.96%	-212.80M 60.98%
short term debt	170K -	24.14M 14,100%	54.27M 124.79%	39.55M 27.12%
short term investments
tax assets
tax payables
total assets	329.96K -	39.35M 11,825.81%	51.37M 30.54%	71.71M 39.60%
total current assets	47.09K -	37.33M 79,165.24%	43.38M 16.23%	64.82M 49.40%
total current liabilities	310.13K -	31.61M 10,092.69%	75.87M 140.00%	65.42M 13.76%
total debt	170K -	26.14M 15,278.24%	59.53M 127.71%	41.86M 29.69%
total investments
total liabilities	310.13K -	73.64M 23,643.29%	122.81M 66.77%	142.20M 15.79%
total liabilities and stockholders equity	329.96K -	39.35M 11,825.81%	51.37M 30.54%	71.71M 39.60%
total non current assets	282.88K -	2.02M 615.86%	7.99M 294.42%	6.90M 13.66%
total non current liabilities		42.02M -	46.94M 11.69%	76.77M 63.56%
total stockholders equity	19.83K -	-34.28M 172,985.89%	-71.44M 108.36%	-70.49M 1.33%

ALUR

NYSE:ALUR

Allurion Technologies Inc.

Last Close

0.68

30/08 20:00

Market Cap

64.25M

Beta: 0.01

Volume Today

121.04K

Avg: 24.32K

PE Ratio

−1.50

PFCF: −2.16

Preview